Substance Use Disorders: Classification and Diagnosis
This area covers how disorders arising from the recurrent use of psychoactive substances are defined, classified, and diagnosed. Contemporary nosology treats substance use disorders as a cluster of cognitive, behavioral, and physiological symptoms indicating that an individual continues using a substance despite significant problems, and it organizes these conditions by substance class while sharing a common set of diagnostic criteria and a graded severity scheme.
Definition
Substance-related and addictive disorders are conditions defined by a problematic pattern of psychoactive substance use leading to clinically significant impairment or distress, classified by substance class and characterized in current systems by impaired control, social impairment, risky use, and pharmacological features such as tolerance and withdrawal.
Scope
The area orients readers to the classification frameworks used in addiction medicine — chiefly the DSM-5 substance use disorder construct and the ICD-11 disorders due to substance use — and to the cross-cutting diagnostic logic that applies across substance classes. It links to topic entries on diagnostic criteria and severity assessment and on the major substance-specific disorders (opioids, alcohol, stimulants, cannabis, nicotine, and others). It is a reference and educational overview of how these disorders are categorized, not a source of diagnostic or treatment instructions.
Sub-topics
Core questions
- How do diagnostic systems define and delimit a substance use disorder?
- What unifies the diagnosis across different substance classes, and what is substance-specific?
- How is severity graded, and what does the dimensional model add to a categorical diagnosis?
- How do DSM-5 and ICD-11 classifications differ in structure and thresholds?
Key concepts
- Substance use disorder construct
- Impaired control over use
- Tolerance and withdrawal
- Severity grading (mild, moderate, severe)
- Dimensional versus categorical classification
- DSM-5 versus ICD-11 frameworks
- Substance classes
Key theories
- Brain disease model of addiction
- A framework conceptualizing addiction as a chronic, relapsing disorder involving disrupted reward, motivation, and executive-control circuitry, used to explain why substance use disorders persist and why they are classified as medical conditions rather than purely volitional behavior.
Mechanisms
Classification systems group these disorders first by the substance involved and then apply a shared diagnostic template. DSM-5 consolidated the older abuse/dependence dichotomy into a single substance use disorder per substance class, with eleven criteria spanning impaired control, social impairment, risky use, and pharmacological criteria, and a severity rating based on the number of criteria met. The brain disease model provides a biological rationale for treating these as medical disorders, linking the diagnostic criteria to underlying changes in reward and control circuitry. The result is a nosology that is partly categorical (a diagnosis is present or absent) and partly dimensional (severity is graded).
Clinical relevance
Understanding how substance use disorders are classified underpins case identification, epidemiologic measurement, and communication across clinical and research settings. This entry describes the structure and rationale of the classification systems; it is educational reference material and does not provide diagnostic thresholds for individual patient care or any treatment recommendations.
Epidemiology
Disorders due to psychoactive substance use are a major contributor to the global burden of disease, with illicit drug dependence alone accounting for a substantial share of disability-adjusted life years, and the burden is unevenly distributed across substances, regions, and age groups.
Evidence & guidelines
The DSM-5 (American Psychiatric Association, 2013) and the WHO ICD-11 provide the principal classification frameworks; the rationale for the DSM-5 substance use disorder criteria was set out by Hasin and colleagues (2013).
History
Twentieth-century nosology distinguished substance abuse from substance dependence, a split carried through DSM-IV. DSM-5 (2013) merged these into a single dimensional substance use disorder per substance class with a severity gradient, and ICD-11 subsequently restructured its own substance-use chapter. These revisions reflected a shift toward viewing addiction along a continuum and grounding it in a neurobiological disease model.
Debates
- Categorical diagnosis versus dimensional severity
- DSM-5's move to a single graded disorder per substance class resolved problems with the abuse/dependence split but raised questions about where to set thresholds and how to interpret mild disorders, a tension that classification systems continue to negotiate.
Key figures
- Nora Volkow
- George Koob
- Deborah Hasin
- Louisa Degenhardt
Related topics
Seminal works
- apa-dsm5-2013
- hasin-2013
- volkow-2016
Frequently asked questions
- What changed in how substance use disorders are classified in DSM-5?
- DSM-5 combined the former categories of substance abuse and substance dependence into a single substance use disorder for each substance class, diagnosed from eleven criteria and graded as mild, moderate, or severe by the number of criteria met.
- Are DSM-5 and ICD-11 the same?
- They cover the same clinical territory but differ in structure and thresholds; DSM-5 uses a single graded disorder per substance class, while ICD-11 retains a distinct configuration of harmful use and dependence within its disorders-due-to-substance-use chapter.